Bvf Inc/il

Investment Portfolio & 13F Holdings Analysis

About

BVF INC/IL is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 51 holdings worth $2.5 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 51
Total Value: 2453567172
Accession Number: 0000921895-25-001528
Form Type: 13F-HR
CIK: 0001056807
Manager Name: Bvf Inc/il

Data Enrichment

96% identified

49 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

51 positions • $2,453,567.172K total value

51 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 3

Sort by:

MoonLake Immunotherapeutics

MLTX|61559X104

19751284(+0.0%)

Value:

$771.7B(-27.8%)

Axsome Therapeutics, Inc.

AXSM|05464T104

1690221(+21.8%)

Value:

$197.1B(+67.8%)

Revolution Medicines, Inc.

RVMD|76155X100

4982384(+19.2%)

Value:

$176.2B(-3.7%)

Kymera Therapeutics, Inc.

KYMR|501575104

5161801(+0.0%)

Value:

$141.3B(-32.0%)

Mirum Pharmaceuticals, Inc.

MIRM|604749101

2796513(+0.0%)

Value:

$126.0B(+8.9%)

Protagonist Therapeutics, Inc

PTGX|74366E102

2575015(+35.5%)

Value:

$124.5B(+69.8%)

GH Research PLC

GHRS|G3855L106

8827712(-15.1%)

Value:

$97.4B(+33.7%)

XOMA Royalty Corp

XOMA|98419J206

2983026(-17.9%)

Value:

$59.5B(-37.7%)

IONIS PHARMACEUTICALS INC

IONS|462222100

1913385

Value:

$57.7B

Zymeworks Inc.

ZYME|98985Y108

4308935(+0.0%)

Value:

$51.3B(-18.6%)

Kura Oncology, Inc.

KURA|50127T109

7754129(+202.0%)

Value:

$51.2B(+128.8%)

Cullinan Therapeutics, Inc.

CGEM|230031106

5750683(+0.0%)

Value:

$43.5B(-37.8%)

AC Immune SA

ACIU|H00263105

19822436(+1.5%)

Value:

$37.1B(-29.7%)

Tyra Biosciences, Inc.

TYRA|90240B106

3944194(+0.0%)

Value:

$36.7B(-33.1%)

GALAPAGOS NV

GLPG|36315X101

1454422(-7.3%)

Value:

$36.5B(-15.3%)

Celcuity Inc.

CELC|15102K100

3466000(+0.0%)

Value:

$35.0B(-22.8%)

Verve Therapeutics, Inc.

VERV|92539P101

6904050(+0.0%)

Value:

$31.6B(-19.0%)

Structure Therapeutics Inc.

GPCR|86366E106

1771417(+0.0%)

Value:

$30.7B(-36.2%)

Xencor Inc

XNCR|98401F105

2740141(+19.7%)

Value:

$29.2B(-44.6%)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

5660132(+104.7%)

Value:

$26.3B(+36.9%)

Instrument	Shares		Other Manager	Value
Moonlake Immunotherapeutics(MLTXcusip61559X104)	19.8M	QoQ 0.00% (-0) YoY -9.19% (-2.0M)	All Managers (Combined)	$771.7M	QoQ -27.84% (-$297.8M) YoY -29.36% (-$320.9M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	1.7M	QoQ +21.76% (+302.2K) YoY NEW(+1.7M)	All Managers (Combined)	$197.1M	QoQ +67.85% (+$79.7M) YoY NEW(+$197.1M)
Revolution Medicines, Inc.(RVMDcusip76155X100)	5.0M	QoQ +19.16% (-801.2K) YoY -16.69% (-998.8K)	All Managers (Combined)	$176.2M	QoQ -3.66% (-$6.7M) YoY -8.60% (-$16.6M)
Kymera Therapeutics, Inc.(KYMRcusip501575104)	5.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$141.3M	QoQ -31.96% (-$66.4M) YoY -31.91% (-$66.2M)
Mirum Pharmaceuticals, Inc.(MIRMcusip604749101)	2.8M	QoQ 0.00% (+0) YoY -36.00% (-1.6M)	All Managers (Combined)	$126.0M	QoQ +8.94% (+$10.3M) YoY +14.76% (-$16.2M)
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	2.6M	QoQ +35.52% (+675.0K) YoY -31.44% (-1.2M)	All Managers (Combined)	$124.5M	QoQ +69.79% (+$51.2M) YoY +14.60% (-$15.9M)
Gh Research Plc(GHRScusipG3855L106)	8.8M	QoQ -15.11% (-1.6M) YoY -15.11% (-1.6M)	All Managers (Combined)	$97.4M	QoQ +33.74% (-$24.6M) YoY -12.17% (-$13.5M)
Xoma Royalty Corp(XOMAcusip98419J206)	3.0M	QoQ -17.90% (-650.7K) YoY -17.90% (-650.7K)	All Managers (Combined)	$59.5M	QoQ -37.74% (-$36.0M) YoY -31.97% (-$27.9M)
Ionis Pharmaceuticals Inc(IONScusip462222100)	1.9M	QoQ NEW(+1.9M) YoY -21.21% (-515.2K)	All Managers (Combined)	$57.7M	QoQ NEW(+$57.7M) YoY -45.16% (-$47.6M)
Zymeworks Inc.(ZYMEcusip98985Y108)	4.3M	QoQ 0.00% (-0) YoY -26.59% (-1.6M)	All Managers (Combined)	$51.3M	QoQ -18.64% (-$11.8M) YoY -16.89% (-$10.4M)
Kura Oncology, Inc.(KURAcusip50127T109)	7.8M	QoQ +202.01% (+5.2M) YoY +62.00% (-3.0M)	All Managers (Combined)	$51.2M	QoQ +128.85% (+$28.8M) YoY -49.87% (-$50.9M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	5.8M	QoQ 0.00% (-0) YoY +79.89% (-2.6M)	All Managers (Combined)	$43.5M	QoQ -37.84% (-$26.5M) YoY -20.08% (-$10.9M)
Ac Immune Sa(ACIUcusipH00263105)	19.8M	QoQ +1.53% (-300.0K) YoY +36.03% (-5.3M)	All Managers (Combined)	$37.1M	QoQ -29.67% (-$15.6M) YoY -14.05% (-$6.1M)
Tyra Biosciences, Inc.(TYRAcusip90240B106)	3.9M	QoQ 0.00% (-0) YoY -15.38% (-717.0K)	All Managers (Combined)	$36.7M	QoQ -33.09% (-$18.1M) YoY -52.01% (-$39.8M)
Galapagos Nv(GLPGcusip36315X101)	1.5M	QoQ -7.32% (-115.0K) YoY -21.96% (-409.4K)	All Managers (Combined)	$36.5M	QoQ -15.34% (-$6.6M) YoY -39.12% (-$23.5M)
Celcuity Inc.(CELCcusip15102K100)	3.5M	QoQ 0.00% (-0) YoY NEW(+3.5M)	All Managers (Combined)	$35.0M	QoQ -22.76% (-$10.3M) YoY NEW(+$35.0M)
Verve Therapeutics, Inc.(VERVcusip92539P101)	6.9M	QoQ 0.00% (-0) YoY +962.16% (+6.3M)	All Managers (Combined)	$31.6M	QoQ -18.97% (-$7.4M) YoY +265.51% (+$22.9M)
Structure Therapeutics Inc.(GPCRcusip86366E106)	1.8M	QoQ 0.00% (-0) YoY +117.88% (-958.4K)	All Managers (Combined)	$30.7M	QoQ -36.17% (-$17.4M) YoY -12.00% (-$4.2M)
Xencor Inc(XNCRcusip98401F105)	2.7M	QoQ +19.72% (-451.4K) YoY NEW(+2.7M)	All Managers (Combined)	$29.2M	QoQ -44.56% (-$23.4M) YoY NEW(+$29.2M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	5.7M	QoQ +104.74% (+2.9M) YoY NEW(+5.7M)	All Managers (Combined)	$26.3M	QoQ +36.89% (+$7.1M) YoY NEW(+$26.3M)